Abstract:The aim of this study was to determine the effect of protein kinase C (PKC) activation on intracellular Ca(2+) transient and its relation to alpha(1)-adrenoceptor (alpha(1)-AR)-stimulated negative inotropic response in rat ventricles. The electromechanical responses to phenylephrine (PE) in rat ventricular muscles were concomitantly examined using the conventional microelectrode method. The responses of intracellular Ca(2+) transient and cell contractions to PE in the absence of certain pharmacological interve… Show more
“…Chen and Su [5] further reported that ␣ 1 -adrenoceptors also mediate negative inotropism in rat ventricular muscles and myocytes, and are due to the activation of PKC. This leads to inhibition of ryanodine-sensitive Ca 2+ -releasing channels [6] and a decrease in the intracellular Ca 2+ transient [14].…”
Section: Protein Kinase C and ␣ ␣ 1 -Adrenoceptor-mediated Negative Imentioning
“…Chen and Su [5] further reported that ␣ 1 -adrenoceptors also mediate negative inotropism in rat ventricular muscles and myocytes, and are due to the activation of PKC. This leads to inhibition of ryanodine-sensitive Ca 2+ -releasing channels [6] and a decrease in the intracellular Ca 2+ transient [14].…”
Section: Protein Kinase C and ␣ ␣ 1 -Adrenoceptor-mediated Negative Imentioning
“…Chen and Su [5] further reported that ␣ 1 -adrenoceptors also mediate negative inotropism in rat ventricular muscles and myocytes, and are due to the activation of PKC. This leads to inhibition of ryanodine-sensitive Ca 2+ -releasing channels [6] and a decrease in the intracellular Ca 2+ transient [14].…”
Section: Protein Kinase C and ␣ ␣ 1 -Adrenoceptor-mediated Negative Imentioning
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.